Product Description
Brand Boditech
Sample Type Serum/ Plasma/ WB
Pack Size 24T
CAT No SMFP-62
Biomarker Hormone Function
AMH levels help predict the remaining egg reserve. This can tell a lot about the reproductive issues, including the onset of menopause, amenorrhea, polycystic ovary syndrome. This test also tells the expected response to controlled ovarian hyperstimulation to achieve pregnancy in IVF.
Rapid, Accurate Ovarian Reserve TestingDesigned for professional use, the AFIAS AMH cartridge empowers healthcare providers with fast and reliable ovarian reserve assessment, optimizing fertility evaluation and reproductive planning. Its high sensitivity (0.08 ng/mL) and rapid turnaround time allow clinics to deliver timely results to patients while maintaining workflow efficiency.
One-Step, Automated Testing WorkflowThe cartridge is ready-to-use with an integrated test strip and reagents, streamlining the diagnostic process. Simply add the required sample type (serum, plasma, or whole blood) to the cartridge and insert it into the compatible AFIAS analyzer. The test is fully automated-no manual calibration is needed-and the analyzer displays results in real time.
Innovative Design and ComplianceEach cartridge features barcoded lot traceability for seamless identification and traceability within the laboratory setting. The product is CE marked for IVD use in India and comes with 12 months' shelf life when stored at 2-8C. Designed for safety and simplicity, the cartridge and materials are for single-use and must be disposed of as biohazard waste according to local regulations.
FAQ's of Boditech AFIAS Anti-Mullerian Hormone (AMH):
Q: How is the Boditech AFIAS AMH cartridge used in clinical settings?
A: To use the Boditech AFIAS AMH cartridge, a professional adds a patient's serum, plasma, or whole blood sample into the cartridge and inserts it into either the AFIAS-1 or AFIAS-6 analyzer. The system processes the sample using an automated fluorescence immunoassay and displays the AMH level within 8-14 minutes.
Q: What are the main benefits of using this AMH test cartridge for ovarian reserve assessment?
A: Key benefits include rapid results (8-14 minutes), high sensitivity (0.08 ng/mL), quantitative accuracy (95%), minimal sample handling, and complete automation without user calibration. This allows for timely and reliable ovarian reserve evaluation crucial for fertility assessment and reproductive health decisions.
Q: When should the AFIAS AMH test be performed?
A: The AFIAS AMH test is typically performed when healthcare providers need to evaluate a woman's ovarian reserve-commonly in fertility workups, before certain gynecological treatments, or when investigating reproductive disorders. The test can be ordered whenever accurate AMH measurement is clinically indicated.
Q: Where can this cartridge be used and who should use it?
A: This cartridge is intended for use in clinical laboratories, fertility clinics, and hospital diagnostic centers. It is strictly for use by professional healthcare personnel trained in in-vitro diagnostic testing, compatible only with AFIAS-1 and AFIAS-6 analyzers.
Q: What types of samples are compatible with the AFIAS AMH cartridge?
A: The cartridge is validated for serum, plasma, or whole blood samples, providing flexibility for diverse patient needs and streamlined blood collection practices in the clinical environment.
Q: How should the AFIAS AMH cartridges be stored and disposed of?
A: Cartridges should be stored at 2-8C, away from direct sunlight to ensure reagent integrity up to their 12-month shelf life. After use, each cartridge must be disposed of as biohazard waste according to local regulatory requirements.
Q: What is the process of result interpretation with the analyzer used for this cartridge?
A: Once the cartridge is processed in the AFIAS analyzer, the device automatically detects, measures, and reports the AMH concentration in ng/mL. The lot barcode on each cartridge ensures precise traceability, and the digital display on the analyzer enables immediate review and electronic documentation of results.